SEC Form 4 · accession 0001106578-26-000093
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Jul 7, 2026
Accepted (ET)
Jul 8, 2026 · 4:47 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 7, 2026 | M | 9,500 | $135.42 | A | 50,013 | D | |
| Common StockF2 | Jul 7, 2026 | S | 200 | $553.1161 | D | 49,813 | D | |
| Common StockF3 | Jul 7, 2026 | S | 241 | $554.3559 | D | 49,572 | D | |
| Common StockF4 | Jul 7, 2026 | S | 596 | $555.5015 | D | 48,976 | D | |
| Common StockF5 | Jul 7, 2026 | S | 726 | $556.554 | D | 48,250 | D | |
| Common StockF6 | Jul 7, 2026 | S | 1,096 | $557.777 | D | 47,154 | D | |
| Common StockF7 | Jul 7, 2026 | S | 1,875 | $558.9003 | D | 45,279 | D | |
| Common StockF8 | Jul 7, 2026 | S | 3,399 | $559.7613 | D | 41,880 | D | |
| Common StockF9 | Jul 7, 2026 | S | 505 | $560.4907 | D | 41,375 | D | |
| Common StockF10 | Jul 7, 2026 | S | 800 | $562.596 | D | 40,575 | D | |
| Common StockF11 | Jul 7, 2026 | S | 62 | $563.2381 | D | 40,513 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common StockF12 | holding | — | — | — | 324,443 | I | By Trust | |
| Common StockF13 | holding | — | — | — | 249,108 | I | By Trust | |
| Common StockF14 | holding | — | — | — | 45,596 | I | By Trust | |
| Common StockF15 | holding | — | — | — | 8,902 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | $135.42 | Jul 7, 2026 | M | 9,500 | D | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 9,500 | 49,218 | D |
| Stock OptionF16 | $135.42 | holding | — | — | — | Mar 15, 2023 | Mar 15, 2027 | Common Stock | 349,192 | 349,192 | I |
Explanation of responses
- F1This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10This transaction was executed in multiple trades at prices ranging from $562.10 to $562.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F11This transaction was executed in multiple trades at prices ranging from $563.16 to $563.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F13Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F14Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F15Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F16Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2This transaction was executed in multiple trades at prices ranging from $552.80 to $553.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $554.06 to $554.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $555.17 to $556.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $556.22 to $557.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $557.30 to $558.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7This transaction was executed in multiple trades at prices ranging from $558.30 to $559.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8This transaction was executed in multiple trades at prices ranging from $559.30 to $560.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9This transaction was executed in multiple trades at prices ranging from $560.32 to $560.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.